TOPRA conferences & networking events

TOPRA holds several high-level conferences and events annually, including our Annual Symposium in a different European city each year and our Annual Summit in London, to discuss issues of high importance to regulatory affairs professionals.

Download TOPRA's Courses & Conferences calendar for 2024 (PDF)

 

Conferences & special events

Begin DateTitleDescriptionCityCountry
29/09/2025TOPRA Symposium 2025 Exhibitor Package - OFFERA truly unique and valuable event in regulatory affairs – the only conference entirely focused on healthcare regulatory affairs allowing you to meet a closely defined group of professionalsBerlinGermanySYM2025EXH

 

TOPRA Special Interest Network (SPIN) events

Start dateTitleDescription
31/10/2024Biotech, Cell & Gene Therapies: Risk Based Approach To ATMPsFollowing on from the successful series of webinars on ATMPs in 2021, Dr Bridget Heelan returns with an updated presentation on the risk based approach to ATMPs.BIOOCT24
22/11/2024UK Regulatory of SaMD and AlaMD - Evolution and OutlookThe pace of developments in the software and AI landscape and the commensurate risks and opportunities posed by healthcare technologies pose an important challenge for regulators.  This webinar will review the evolution of UK policy and guidance on Software as a Medical Device and AI as a Medical Device and provide an outlook on upcoming developments.SAMDANOV24
10/12/2024EU AI Act Implementation for Medical DevicesAn overview of the impact of the EU AI Act for medical devices, key milestones and practical recommendation for compliance by medical device manufacturers.SAMDDEC24

 

TOPRA In regional networking events

Start dateTitleDescriptionCityCountry
22/10/2024Health Economics From a Regulatory PerspectiveHealth economics and Health Technology Assessment (HTA) during the development of a new drug are becoming increasingly important. If a drug is to reach the patient after regulatory approval, it must undergo a health economic evaluation, a basis for pricing and decisions on subsidies. This takes place at national level in the various EU countries. Hear from TLV and Industry about the new EU HTA Regulation (EU) 2021/2282 (HTAR) which will be applied from January 2025 for certain medicines, Joint Clinical Assessment (JCA) and HTA strategy during drug development. This evening is an excellent opportunity to hear the latest in this field. You also get the opportunity to meet colleagues in a relaxed and sociable setting.UppsalaSwedenSWEOCT24
29/10/2024Navigating Regulatory Changes in Moldova and UkraineJoin this webinar to explore regulatory strategies in Moldova and Ukraine during this complex period and the roadmap to integration with the EU. OnlineMDUAOCT24
20/11/2024Clinical Trials with Drugs, Medical Devices and ATMPClinical trials in Europe follow different rules and regulations, CTR, MDR, IVDR and combined studies have their challenges. We hear about COMBINE, experiences with clinical trials of drugs, medical devices, combination products, ATMP (cell and gene therapies) and some news about TOPRA. You get the opportunity to meet colleagues in a relaxed and pleasant environment. The meeting is open to anyone who works with and is interested in regulatory affairs.MölndalSwedenSWENOV24